Hemp retailers in Missouri are trying to work with state lawmakers to place regulations on an industry that still exists unregulated in a legal loophole.
Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...